Black Doctor Hadiyah-Nicole Green Makes History

Black Doctor Hadiyah-Nicole Green Makes History As The First Person To Successfully Cure Cancer Using Laser-Activated Nanoparticles

Dr. Hadiyah-Nicole Green, a physicist and cancer researcher, recently achieved a scientific breakthrough – becoming the first person to successfully cure cancer in mice using laser-activated nanoparticles.

Her groundbreaking solution demonstrates the immense potential for affordable, non-invasive cancer therapy in humans.

Harnessing The Power of Light

Dr. Green’s award-winning technique utilizes FDA-approved nanoparticles that specifically target cancer cells when injected into the patient.

Tracking imagery then pinpoints the cancer sites before a laser illuminates the nanoparticles, producing reactive oxygen that destroys the malignant tissue while leaving healthy cells intact.

In animal trials, Dr. Green’s one-time laser treatment eradicated tumors in mice with various cancer types. No observable side effects occurred over 16 days of observation post-treatment. The non-invasive method avoids the painful symptoms of procedures like chemotherapy and radiation.

Driven By A Personal Quest

Dr. Green’s passion for developing a better cancer cure stems from painful losses in her family. Her beloved aunt and uncle, who raised her, both died of cancer after struggling immensely with conventional treatments.

Their suffering inspired Dr. Green’s mission to create an affordable, accessible therapy that improves quality of life during the healing process.

Bringing The Cure To Humanity

To fund clinical trials required to make her treatment available to cancer patients, Dr. Green established a non-profit organization that has already received $1.1 million in grants.

However, realizing her dream of universal access requires over $90 million more. Dr. Green also aims to keep costs low enough for the average patient.

At just 35 years old, Dr. Green is already an influential voice in healthcare innovation as one of few Black women physicists nationwide. Her perseverance through funding challenges is now bringing life-changing medicine within reach.